Nalaganje...
Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
ESSENTIALS: Factor VIII inhibitors are the most serious complication in patients with hemophilia A. Aggregates in biopharmaceutical products are an immunogenic risk factor. Aggregates were identified in recombinant full‐length factor VIII products. Aggregates in recombinant factor VIII products are...
Shranjeno v:
| izdano v: | J Thromb Haemost |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5809250/ https://ncbi.nlm.nih.gov/pubmed/29197156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13917 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|